Alprostadil (Caverject/MUSE) Adolescent (Ages 12 to 17) Dosing
An evidence-based review of alprostadil for adolescents ages 12 to 17, including the absence of an established pediatric dose, specialist evaluation, product-label limits, and urgent safety guidance.
